Los Angeles Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $462K | Buy |
4,424
+2,686
| +155% | +$280K | ﹤0.01% | 882 |
|
|
2025
Q1 | $203K | Buy |
+1,738
| New | +$203K | ﹤0.01% | 1008 |
|
|
2021
Q2 | – | Sell |
-4,971
| Closed | -$281K | – | 1535 |
|
|
2021
Q1 | $281K | Sell |
4,971
-4,349
| -47% | -$246K | ﹤0.01% | 1453 |
|
|
2020
Q4 | $759K | Buy |
9,320
+125
| +1% | +$10.2K | ﹤0.01% | 1046 |
|
|
2020
Q3 | $655K | Hold |
9,195
| – | – | ﹤0.01% | 982 |
|
|
2020
Q2 | $757K | Buy |
9,195
+830
| +10% | +$68.3K | ﹤0.01% | 954 |
|
|
2020
Q1 | $492K | Buy |
+8,365
| New | +$492K | ﹤0.01% | 908 |
|